2025 annual financial data
Aldeyra Therapeutics 2025 Operating margin
Aldeyra Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -35,265,206 USD and net income was -33,846,661 USD.
Operating cash flow was -33,345,682 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -35,265,206 USD
- Net income
- -33,846,661 USD
- Operating cash flow
- -33,345,682 USD